Macrophages in Atherosclerosis, First or Second Row Players?

Area of Science:

• Cardiovascular Research
• Cell Biology
• Pathophysiology

Background:

• Macrophages have long been implicated in atherosclerosis, contributing to inflammation and foam cell formation.
• Recent studies reveal vascular smooth muscle cells (VSMCs) possess plasticity, differentiating into macrophage-like cells within plaques.

Purpose of the Study:

• To critically evaluate the roles of macrophages versus VSMCs in all stages of atherosclerosis.
• To analyze the utility of animal models for human atherosclerosis research.
• To discuss therapeutic strategies targeting VSMCs or macrophages.

Main Methods:

• Literature review and critical analysis of existing evidence.
• Comparison of findings from animal models and human studies.
• Discussion of cellular plasticity and differentiation pathways.

Main Results:

• Evidence supports both macrophage and VSMC contributions to atherosclerotic plaque development.
• VSMC plasticity challenges the traditional view of macrophages as the sole key players.
• Animal models provide valuable insights but human-specific mechanisms require further investigation.

Conclusions:

• Atherosclerosis pathogenesis involves complex interactions between macrophages and VSMCs.
• Targeting either cell type presents potential therapeutic avenues for cardiovascular events.
• Further research is essential to fully elucidate and prevent human atherosclerotic plaque development.